Background - Survival following pulmonary resection for primary lung c
ancer is considered to be principally dependent on the clinical stage
of the disease. A study was undertaken to verify this and to identify
other contributing factors. Methods - The case records of all patients
who underwent surgery for lung cancer over a two year period between
January 1987 and December 1988 were reviewed retrospectively. Results
- One hundred and forty seven lobectomies and 60 pneumonectomies were
performed with 2.8% and 5.3% operative mortality, respectively Squamou
s carcinoma was the commonest pathology (60%) followed by adenocarcino
ma (30%). The overall five year survival was 45.5% (95% CI 44.1% to 57
.9%). There were 123 patients with stage I disease, 40 with stage II,
and 37 in stage IIIa with five year survival of 59.4% (95% CI 50.8% to
68%), 30% (95% CI 15.9% to 44.1%), and 16.2% (95% CI 3.5% to 31%), re
spectively. There were no differences in survival with respect to sex,
extent of resection, or cell type. In patients with stage II disease
the five year survival of those with T1 lesions (50%, 95% CI 37.3% to
62.9%) was better than those with T2 (28.1%, 95% CI 16.9% to 39.3%). O
f eight patients over the age of 70 with stage IIIa disease none survi
ved more than 24 months. Conclusions - Stage at operation is the most
accurate predictor of long term survival in early lung cancer and surg
ery remains an effective treatment, particularly in stage I and II dis
ease. Further study is needed to assess the prognostic value of subdiv
iding stage II disease into T1 and T2 lesions. Major resection for loc
ally advanced disease in older patients may be relatively ineffective.